Afficher la notice abrégée

dc.contributor.authorPeña-Martín, María Celsa
dc.contributor.authorGarcía-Berrocal, Belén
dc.contributor.authorSánchez Martín, Almudena
dc.contributor.authorMarcos-Vadillo, Elena
dc.contributor.authorGarcía-Salgado, María Jesús
dc.contributor.authorSánchez, Santiago
dc.contributor.authorLorenzo Romo, Carolina 
dc.contributor.authorGonzález-Parra, David
dc.contributor.authorSans, Francisco
dc.contributor.authorFranco Martín, Manuel Ángel 
dc.contributor.authorGaedigk, Andrea
dc.contributor.authorMateos-Sexmero, María José
dc.contributor.authorSanz Lozano, Catalina Sofía 
dc.contributor.authorIsidoro García, María 
dc.date.accessioned2024-06-27T09:58:16Z
dc.date.available2024-06-27T09:58:16Z
dc.date.issued2022-01-11
dc.identifier.citationPeña-Martín, M. C., García-Berrocal, B., Sánchez-Martín, A., Marcos-Vadillo, E., García-Salgado, M. J., Sánchez, S., Lorenzo, C., González-Parra, D., Sans, F., Franco, M., Gaedigk, A., Mateos-Sexmero, M. J., Sanz, C., & Isidoro-García, M. (2022). Ten Years of Experience Support Pharmacogenetic Testing to Guide Individualized Drug Therapy. Pharmaceutics, 14(1). https://doi.org/10.3390/PHARMACEUTICS14010160. PMID: 35057056; PMCID: PMC8779486.es_ES
dc.identifier.urihttp://hdl.handle.net/10366/158648
dc.description.abstract[EN]Precision medicine utilizing the genetic information of genes involved in the metabolism and disposition of drugs can not only improve drug efficacy but also prevent or minimize adverse events. Polypharmacy is common among multimorbid patients and is associated with increased adverse events. One of the main objectives in health care is safe and efficacious drug therapy, which is directly correlated to the individual response to treatment. Precision medicine can increase drug safety in many scenarios, including polypharmacy. In this report, we share our experience utilizing precision medicine over the past ten years. Based on our experience using pharmacogenetic (PGx)-informed prescribing, we implemented a five-step precision medicine protocol (5SPM) that includes the assessment of the biological-clinical characteristics of the patient, current and past prescription history, and the patient's PGx test results. To illustrate our approach, we present cases highlighting the clinical relevance of precision medicine with a focus on patients with a complex history and polypharmacy.en_EN
dc.description.sponsorshipInstituto de Salud Carlos III; European Regional Development Fundes_ES
dc.language.isoenges_ES
dc.publisherMDPIen_EN
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectPharmacogeneticsen_EN
dc.subjectPolypharmacyen_EN
dc.subjectPrecision medicineen_EN
dc.subject.meshGenetics *
dc.subject.meshAllergy and Immunology *
dc.titleTen Years of Experience Support Pharmacogenetic Testing to Guide Individualized Drug Therapyen_EN
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/10.3390/pharmaceutics14010160es_ES
dc.subject.unesco3207.01 Alergiases_ES
dc.subject.unesco2409 Genéticaes_ES
dc.identifier.doi10.3390/pharmaceutics14010160
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.pmid35057056
dc.identifier.essn1999-4923
dc.journal.titlePharmaceuticsen_EN
dc.volume.number14es_ES
dc.issue.number1es_ES
dc.page.initial160es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decsalergia e inmunología *
dc.subject.decsgenética *


Fichier(s) constituant ce document

Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NonCommercial-NoDerivatives 4.0 Internacional